500 lung cancer patients enrolled in quest for smarter radiotherapy
NCT ID NCT07565532
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is gathering detailed information from 500 people with small cell lung cancer to learn how to tailor treatments like radiation and immunotherapy to each patient. The goal is to find the best timing and doses of radiotherapy to work with immunotherapy, improving outcomes and reducing side effects. Participants will be followed over time to track cancer progression and survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, 200030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple supplement soothe Radiation-Damaged rectums?
- Engineered immune cells take aim at stubborn lung cancer
- Could a hidden nerve condition be more common in lung cancer than we think?
- Can imaging reveal how radiation shapes marrow recovery?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can an AI coach and simple exercises help cancer patients fight frailty?